Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The GABAA receptor beta subunit is an essential component of the GABAA receptor, a major inhibitory neurotransmitter receptor in the mammalian brain. It forms part of the pentameric receptor complex responsible for mediating fast synaptic inhibition via chloride ion influx upon GABA binding. Three beta subunit isoforms (β1, β2, β3) exist, each contributing to distinct receptor properties and drug binding sites. The presence of at least one beta subunit is required for functional receptor assembly. Beta subunits are implicated in various neurological and psychiatric disorders due to their role in inhibitory neurotransmission.
Agonist binding leading to chloride ion channel opening and neuronal hyperpolarization.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GABAA Receptor Beta Subunit (GABAAR β).